{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T22:09:40Z","timestamp":1755036580961},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Alport syndrome is a hereditary nephropathy caused by mutations in collagen IV genes and characterized by ultrastructural lesions of the glomerular basement membrane. Some patients have a negative family history with apparently de novo mutations. Although somatic mosaicism has been postulated, as cryptic mosaicism cannot be detected from mutational screening on peripheral blood samples, cases in kidney-confined mosaic form have been missed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We report the case of a 24-year-old male patient with X-linked Alport syndrome diagnosis due to a <jats:italic toggle=\"yes\">COL4A5<\/jats:italic> pathogenic mutation (c.3334_3337dup [p.Gly1113Alafs<jats:sup>*<\/jats:sup>25]). The same mutation had not been previously detected on a peripheral blood sample of maternal DNA. However, the mother, who was undertaking a clinical re-evaluation to take in consideration the possibility of a living-kidney transplantation, had experienced persistent microhematuria since the age of 10 years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>A next-generation sequencing approach performed on maternal DNA from both peripheral blood sample and urine-derived podocyte-lineage cells unmasked the <jats:italic toggle=\"yes\">COL4A5<\/jats:italic> mutation only in the podocyte-lineage cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>This finding unveils an early postzygotic event which can explain both the renal involvement and germline mosaicism. It changes the inheritance risk for each pregnancy raising it to 50% and underlines the need for different clinical management in the mother. This seems to indicate that a case-by-case more cautious approach is needed with mother-to-son kidney transplants.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000003104","type":"journal-article","created":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T21:05:05Z","timestamp":1577912705000},"page":"2360-2364","source":"Crossref","is-referenced-by-count":5,"title":["Detection of Cryptic Mosaicism in X-linked Alport Syndrome Prompts to Re-evaluate Living-donor Kidney Transplantation"],"prefix":"10.1097","volume":"104","author":[{"given":"Anna Maria","family":"Pinto","sequence":"first","affiliation":[{"name":"Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Daga","sequence":"additional","affiliation":[{"name":"Medical Genetics, University of Siena, Siena, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Fallerini","sequence":"additional","affiliation":[{"name":"Medical Genetics, University of Siena, Siena, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirella","family":"Bruttini","sequence":"additional","affiliation":[{"name":"Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy."},{"name":"Medical Genetics, University of Siena, Siena, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Baldassarri","sequence":"additional","affiliation":[{"name":"Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annarita","family":"Giliberti","sequence":"additional","affiliation":[{"name":"Medical Genetics, University of Siena, Siena, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Frullanti","sequence":"additional","affiliation":[{"name":"Medical Genetics, University of Siena, Siena, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Guarnieri","sequence":"additional","affiliation":[{"name":"U.O.C. Nefrologia, Azienda Ospedaliera Universitaria Senese, Siena, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Garosi","sequence":"additional","affiliation":[{"name":"U.O.C. Nefrologia, Azienda Ospedaliera Universitaria Senese, Siena, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Renieri","sequence":"additional","affiliation":[{"name":"Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy."},{"name":"Medical Genetics, University of Siena, Siena, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,12,31]]},"reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2011.237","article-title":"Clinical utility gene card for: Alport syndrome.","volume":"20","author":"Hertz","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncpneph0671","article-title":"Inherited diseases of the glomerular basement membrane.","volume":"4","author":"Gubler","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/ki.1985.63","article-title":"Genetic heterogeneity of Alport syndrome.","volume":"27","author":"Feingold","year":"1985","journal-title":"Kidney Int"},{"key":"R4-20231002","first-page":"314","article-title":"Type-IV collagen related diseases.","volume":"16","author":"Pescucci","year":"2003","journal-title":"J Nephrol"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1681\/ASN.2012020148","article-title":"Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy.","volume":"24","author":"Savige","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R6-20231002","first-page":"1192","article-title":"X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene.","volume":"58","author":"Renieri","year":"1996","journal-title":"Am J Hum Genet"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/humu.23364","article-title":"Urine-derived podocytes-lineage cells: a promising tool for precision medicine in Alport syndrome.","volume":"39","author":"Daga","year":"2018","journal-title":"Hum Mutat"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ejhg.2015.113","article-title":"Somatic mosaicism and variant frequency detected by next-generation sequencing in X-linked Alport syndrome.","volume":"24","author":"Fu","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1046\/j.1523-1755.2002.00379.x","article-title":"COL4A3\/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.","volume":"61","author":"Longo","year":"2002","journal-title":"Kidney Int"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1523-1755.2004.00560.x","article-title":"Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene.","volume":"65","author":"Pescucci","year":"2004","journal-title":"Kidney Int"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/cge.12502","article-title":"Detecting somatic mosaicism: considerations and clinical implications.","volume":"87","author":"Cohen","year":"2015","journal-title":"Clin Genet"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/jmg.37.3.238","article-title":"Somatic mosaicism associated with a mild alport syndrome phenotype.","volume":"37","author":"Plant","year":"2000","journal-title":"J Med Genet"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.gene.2013.05.045","article-title":"Next generation sequencing as a useful tool in the diagnostics of mosaicism in Alport syndrome.","volume":"526","author":"Beicht","year":"2013","journal-title":"Gene"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s10157-016-1352-y","article-title":"Female X-linked Alport syndrome with somatic mosaicism.","volume":"21","author":"Yokota","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/jmg.37.9.717","article-title":"Mosaicism in Alport syndrome with genetic counselling.","volume":"37","author":"Bruttini","year":"2000","journal-title":"J Med Genet"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40620-018-0518-y","article-title":"Germline mosaicism is a pitfall in the diagnosis of \u201csporadic\u201d X-linked Alport syndrome.","volume":"32","author":"Okamoto","year":"2019","journal-title":"J Nephrol"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00467-012-2372-9","article-title":"Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome.","volume":"28","author":"Webb","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"R18-20231002","first-page":"1492743","article-title":"Podocyturia: a clue for the rational use of amiloride in Alport renal disease.","volume":"2016","author":"Trimarchi","year":"2016","journal-title":"Case Rep Nephrol"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1681\/ASN.2005020159","article-title":"Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria.","volume":"16","author":"Yu","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2353\/jmoldx.2007.060155","article-title":"The human androgen receptor X-chromosome inactivation assay for clonality diagnostics of natural killer cell proliferations.","volume":"9","author":"Boudewijns","year":"2007","journal-title":"J Mol Diagn"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:22:02Z","timestamp":1696224122000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,31]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003104","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,31]]}}}